Aspirin And Extended-Release Dipyridamole NDC 63629-5045

NDC codes

FDA NDC Directory

Product NDC (as listed)63629-5045Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63629-5045Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63629-5045-1	63629504501	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-5045-1)Marketed from Jan 28, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aspirin And Extended-Release Dipyridamole
Generic name (nonproprietary): aspirin and extended-release dipyridamole
Active ingredients: Aspirin — 25 mg/1Dipyridamole — 200 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209929
Marketing start: Aug 16, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)
Identifiers: Product ID 63629-5045_3f5911c3-e5a2-4e5c-8ef2-630cac4772e7SPL ID 3f5911c3-e5a2-4e5c-8ef2-630cac4772e7SPL set ID 4f0ac35b-dc0d-4a73-92d1-a6153ff61feaRxCUI 259081UNII R16CO5Y76E, 64ALC7F90C
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629504501 followed by a unit qualifier and the quantity

Package 63629-5045-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2025.

Indications (excerpt from the label)

Aspirin and extended-release dipyridamole capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and extended-release dipyridamole capsule is a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209929

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209929
Product	Strength	Form · route	Labeler	Product NDC
Aspirin And Extended-Release Dipyridamole	Aspirin 25 mg/1; Dipyridamole 200 mg/1	Capsule, Extended releaseOral	Micro Labs Limited	42571-274